Mercer Global Advisors’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Mercer Global Advisors’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$682	Buy	+12	New	+$572	﹤0.01%	5786

Other funds holding GNOM

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

OAM

Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return

AAP

Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return

SWP

Stratos Wealth Partners Beachwood, Ohio $9.93B AUM 28.91% 1-Year Est. Return

CFD

Creative Financial Designs Kokomo, Indiana $2.1B AUM 23.1% 1-Year Est. Return

SLT Holdings Scottsdale, Arizona $160M AUM 52.3% 1-Year Est. Return

WMP

Wealth Management Partners Tucson, Arizona $425M AUM 60.71% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

SWA

Sightline Wealth Advisors Groton, Connecticut $273M AUM 18.08% 1-Year Est. Return

Mercer Global Advisors's GNOM Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Global X Genomics & Biotechnology ETF (GNOM) in Q2 2026: 12 shares worth $682. The stake represents ﹤0.01% of the portfolio and ranks #5786 among its holdings.

36 funds tracked by Wall St. Rank hold GNOM as of Q2 2026.

Mercer Global Advisors held 12 shares of Global X Genomics & Biotechnology ETF worth $682 as of Q2 2026.
Global X Genomics & Biotechnology ETF was a new Mercer Global Advisors position in Q2 2026.
Global X Genomics & Biotechnology ETF made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #5786 holding.
36 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.